Clinical Trial Update: A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray [Phase 4]

View source ↗

Summary

This Phase 4 pilot trial comparing hypotonic and isotonic formulations of ciclesonide nasal spray for allergic rhinitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• ciclesonide (ciclesonide)

Snippet

Sponsor: University of Chicago | Conditions: Allergic Rhinitis | Phase 4 | Status: WITHDRAWN